# Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation

> **NCT06647459** · — · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 32 (actual)

## Conditions studied

- Ventricular Tachycardia
- Atrial Fibrillation

## Interventions

- **DIAGNOSTIC_TEST:** EP Study

## Key facts

- **NCT ID:** NCT06647459
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-13
- **Primary completion:** 2026-04-28
- **Final completion:** 2026-04-28
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Grant proposal was sent to NIH 3 times but did not score well enough to receive funding
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06647459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06647459, "Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06647459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*